
Join to View Full Profile
825 Eastlake Ave ESeattle, WA 98109
Phone+1 206-520-5000
Dr. Banerjee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Rahul Banerjee, MD, FACP, (Twitter/X: @RahulBanerjeeMD) is an Assistant Professor at the Fred Hutchinson Cancer Center and at the University of Washington in Seattle, Washington, USA. His clinical interests are in multiple myeloma and CAR-T therapy. He is a member of the International Myeloma Working Group and has published over 100 peer-reviewed publications with an emphasis on improving the experiences of patients as they undergo treatment for multiple myeloma.
Education & Training
University of California San FranciscoAdvanced Fellowship, BMT/CAR-T Therapy, 2021 - 2022
University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2018 - 2021
University of Pennsylvania Health SystemChief Residency, Internal Medicine, 2017 - 2018
University of Pennsylvania Health SystemResidency, Internal Medicine, 2014 - 2017
University of Pennsylvania Health SystemInternship, Internal Medicine, 2014 - 2015
The Warren Alpert Medical School of Brown UniversityClass of 2014, MD, AOA Inductee
Certifications & Licensure
CA State Medical License 2018 - 2028
WA State Medical License 2022 - 2027
AK State Medical License 2025 - 2026
ID State Medical License 2024 - 2026
MT State Medical License 2024 - 2026
PA State Medical License 2014 - 2018
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Winner, Department of Medicine ‘Shelter-in-Poetry’ Competition University of California San Francisco, 2020
- Penn Pearls Award Recipient Perelman School of Medicine, University of Pennsylvania, 2017
- Samaha Award for resident scholarship Penn Medicine, 2017
- Join now to see all
Clinical Trials
- Digital Life Coaching for Myeloma Patients Undergoing Transplantation Start of enrollment: 2020 May 20
- Randomized Study of Digital Life Coaching in Myeloma Patients Undergoing Transplantation Start of enrollment: 2020 Dec 29
- Real World Insights During Treatment for Relapsed/Refractory Multiple Myeloma with Isatuximab Start of enrollment: 2022 Jun 17
- Join now to see all
Publications & Presentations
PubMed
- Predictors of Delayed Responses to Teclistamab in Multiple Myeloma After Initial Non-Response.Rahul Banerjee, Gurbakhash Kaur, Beatrice M Razzo, Andrew J Portuguese, Surbhi Sidana
American Journal of Hematology. 2025-10-11 - Vaccination during bispecific antibody treatment for myeloma.Rahul Banerjee, Noopur S Raje
Blood Advances. 2025-10-08 - Assessing Quality of Life and Symptoms in Transplantation and CAR-T Recipients: Expert Panel Recommendations from the Survivorship Special Interest Group of ASTCT.Rahul Banerjee, Hermioni L Amonoo, Anna Barata, Neel S Bhatt, Manuel R Espinoza-Gutarra
Transplantation and Cellular Therapy. 2025-10-01
Journal Articles
- IlliteracyBanerjee R, The Pharos of Alpha Omega Alpha Honor Medical Society, 2/21/2017
Books/Book Chapters
Press Mentions
Dr Rahul Banerjee’s Top 6 Presentations From IMS 2025September 22nd, 2025
IMS 2025: Future Directions for CAR T Therapy in Relapsed and Refractory Multiple MyelomaSeptember 17th, 2025
First-Of-Its-Kind Roadmap Aims to Get Bispecifics Into Community Cancer ClinicsAugust 25th, 2025- Join now to see all
Grant Support
- Young Investigator AwardASCO Conquer Cancer Foundation2020–2022
Professional Memberships
- Member
- Member
- Member
- Member
- American Society for Transplantation and Cellular TherapyMember
- Member
Other Languages
- Hindi, Bengali
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









